formulation comprising 1-h-quinazoline-2,4-dione ampoule receptor antagonists in the form of immediate release tablets and preparation thereof
- 专利权人:
- NOVARTIS AG
- 发明人:
- JOHN VRETTOS,JOSEPH LAWRENCE ZIELINSKI,QIN JI,SUBASH PATEL
- 申请号：
- BR112012016920
- 公开号：
- BR112012016920A2
- 申请日:
- 2010.12.21
- 申请国别(地区):
- BR
- 年份:
- 2016
- 代理人:
- 摘要：
- The present invention relates to pharmaceutical formulations comprising a 1H-quinazoline-2,4-dione AMPA receptor antagonist. More particularly, the invention relates to immediate release formulations comprising such a compound.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- FORMULATION COMPRISING 1H-QUINAZOLINE-2,4-DIONE AMPA RECEPTOR ANTAGONISTS, IN THE FORM OF IMMEDIATE RELEASE TABLETS AND PREPARATION THEREOF
- FORMULATION COMPRISING 1H-QUINAZOLINE-2,4-DIONE AMPA RECEPTOR ANTAGONISTS,IN THE FORM OF IMMEDIATE RELEASE TABLETS AND PREPARATION THEREOF
- FOMULATION COMPRISING 1 H-QUINAZOLINE-2, 4-DIONE AMPA RECEPTOR ANTAGONISTS, IN THE FORM OF IMMEDIATE RELEASE TABLETS AND PREPARATION THEREOF
- Formulation including 1 h-quinazolin-2, 4-diona receptor antagonism in the form of immediate release and preparation of 1 h-quinazolin-2, 4-diona including 1 h-quinazolin-2, 4-diona receptor antagonism in FOV
- COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN OPIOID AGENT
